A New Pioneer Factor Identified Underlying Progression In Breast Cancer
11/20/2011

The presence of a new pioneer factor, known as PBX1, can guide the response to estrogen in breast cancer cells according to researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center in results published in the open-access journal PLoS Genetics...

Global Prevalence Study Of Infections In Urology And The ESIU-EAU Prostate Biopsy Side Study Run Until The End Of November
11/19/2011

Qualified urologists and urology departments collaborating with microbiologists and infectious disease specialists are encouraged to join the new Global Prevalence Study of Infections in Urology (GPIU) with the last five calendared dates taking place this week and by the end of this month...

Merrimack Pharmaceuticals Initiates Enrollment In Phase 2 Study Of MM-121 In Combination With Erlotinib In Three Groups Of Patients With Lung Cancer
11/19/2011

Merrimack Pharmaceuticals, Inc. announced that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib (Tarceva®), a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer (NSCLC)...

Old Drugs Find New Target For Treating Brain Tumor
11/19/2011

Scientists at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center, in collaboration with colleagues in Boston and South Korea, say they have identified a novel gene mutation that causes at least one form of glioblastoma (GBM), the most common type of malignant brain tumor...

Omega-3 Supplementation May Reduce Joint And Cognitive Side Effects Of Breast Cancer Treatments
11/19/2011

"I know I need this medicine to help lower my chance of cancer recurrence, but it makes my joints ache and stiff. It makes me feel old and I am not sure I can take this medication much longer...

Avastin Approval For Breast Cancer Removed, FDA
11/19/2011

Avastin's approval for the treatment of breast cancer has been revoked, the FDA (Food and Drug Administration) announced today. The US regulatory agency says that Avastin is neither effective nor safe for that particular type of cancer...

Researchers Discover New Way To Form Extracellular Vesicles
11/18/2011

Researchers at NYU Langone Medical Center have discovered a protein called TAT-5 that affects the production of extracellular vesicles, small sacs of membrane released from the surface of cells, capable of sending signals to other cells. When released extracellular vesicles can affect tumor spread, blood clotting and inflammation...

Molecules On Branched-Polymer Surfaces Can Capture Rare Tumor Cells In Blood
11/18/2011

The removal of rare tumor cells circulating in the blood might be possible with the use of biomolecules bound to dendrimers, highly branched synthetic polymers, which could efficiently sift and capture the diseased cells, according to new research at the University of Illinois at Chicago...

Malaria Drug Studied For Treatment Of Metastatic Breast Cancer
11/18/2011

An anti-malaria drug used for more than 60 years is now being studied for use in breast cancer patients whose disease has not responded to traditional chemotherapy treatment. Dr...

Discovery Has The Potential To Help Fight Ovarian Cancer
11/18/2011

A potential breakthrough in treating late-stage ovarian cancer has come from University of Guelph researchers who have discovered a peptide that shrinks advanced tumours and improves survival rates for this deadly but often undetected disease...